These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 7580745)

  • 1. [The correlation of the electroencephalographic and clinical effects of benzodiazepine tranquilizers in patients with mental disorders at the neurotic level].
    Bochkarev VK; Neznamov GG
    Eksp Klin Farmakol; 1995; 58(4):18-22. PubMed ID: 7580745
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of psychophysiologic indices for the prognosis of the clinical action of tranquilizers].
    Aleksandrovskiĭ IuA; Ben'kovich BI; Marshak OV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(12):90-8. PubMed ID: 2907706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of tranquilizers on the critical flicker fusion frequency in the visual analyzer].
    Ben'kovich BI; Marshak OV
    Fiziol Cheloveka; 1984; 10(6):999-1004. PubMed ID: 6151932
    [No Abstract]   [Full Text] [Related]  

  • 4. [Tranquilizers in the combined treatment of patients with arterial hypertension].
    Vanchakova NP; Skvortsov NL
    Vrach Delo; 1988 Aug; (8):48-50. PubMed ID: 2905095
    [No Abstract]   [Full Text] [Related]  

  • 5. [Open clinical trial with pinazepam].
    Corni L; Palmarin R
    Clin Ter; 1976 Aug; 78(3):219-26. PubMed ID: 12907
    [No Abstract]   [Full Text] [Related]  

  • 6. [The therapeutic efficacy and the effect of gidazepam and fenazepam on the psychophysiological status and on the performance of operators with mental disorders at a neurotic level].
    Neznamov GG; Morozov IS; Barchukov VG; Teleshova ES; Siuniakov SA; Zhirov EN; Tkachev AE; Belyĭ IuN; Kolotilinskaia NV; Safarova TP; Barannikov AS; Chernyĭ AV; Shestopalov SS
    Eksp Klin Farmakol; 1997; 60(4):17-21. PubMed ID: 9376749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation of the clinical pharmacological action of a single dose of fenazepam with the EEG dynamics and pharmacokinetics].
    Uvarova LG; Zherdev VP; Neznamov GG; Khrulenko-Varnitskiĭ IO; Sigunova EA
    Farmakol Toksikol; 1986; 49(1):66-9. PubMed ID: 2868919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neurotic inhibition and transnosographic approach. Apropos of a multicenter study of carpipramine].
    Ferreri M; Alby JM
    Encephale; 1987; 13(6):357-65. PubMed ID: 2897281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Double blind comparative clinical evaluation of a new anxiolytic agent, Zami-905: propazepam].
    Carbonell Masía DC; Calvé Pérez A
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1976; 4(6):377-86. PubMed ID: 19933
    [No Abstract]   [Full Text] [Related]  

  • 10. [Double-blind test with a new benzodiazepine derivative (camazepam)].
    Meusert W
    Med Monatsschr; 1976 Sep; 30(9):413-5. PubMed ID: 10518
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of tranquilizers on critical flicker fusion frequency in the visual system.
    Ben'kovich BI; Marshak OV
    Hum Physiol; 1984; 10(6):435-9. PubMed ID: 6544738
    [No Abstract]   [Full Text] [Related]  

  • 12. [Differential pharmacotherapy of neurotic conditions (comparative effectiveness of benzodiazepine derivatives)].
    Smulevich AB; Mazaeva NA; Golovanova LA; Dubnitskaia EB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976; 76(2):255-62. PubMed ID: 4938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of bemitil pharmacokinetics in realizing its therapeutic efficacy].
    Boĭko SS; Zherdev VP; Neznamov GG
    Farmakol Toksikol; 1991; 54(2):64-6. PubMed ID: 1679400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the safety and therapeutic effects of lorazepam on long-term use.
    Siassi I; Thomas M; Vanov SK
    Curr Ther Res Clin Exp; 1975 Jul; 18(1 pt 2):163-71. PubMed ID: 240649
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinico-pharmacologic analysis neurovegetotropic activity of tranquilizers].
    Aleksandrovskiĭ IuA; Ben'kovich BI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(5):743-50. PubMed ID: 6464592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proceedings: EEG changes in the treatment with medazepam and oxazepam. A cross over study.
    Misurec J; Náhunek K
    Act Nerv Super (Praha); 1975; 17(4):276-7. PubMed ID: 3935
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinicobiochemical parallels in borderline neuropsychic disorders].
    Ushakov GK; Maslova AF; Kostiunina ZG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(11):1663-6. PubMed ID: 6119860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results achieved with clozapine (leponex) in the treatment of neuroses.
    Nica S; Ciurezu T; Udangiu L
    Act Nerv Super (Praha); 1974 Aug; 16(3):201-2. PubMed ID: 4153861
    [No Abstract]   [Full Text] [Related]  

  • 19. [Relation between the effect of tranquilizers and various features of personality structure among patients with borderline states].
    Aleksandrovskiĭ IuA; Khrulenko-Varnitskiĭ IO; Uvarova LG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(9):1367-76. PubMed ID: 6506985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neurological complications following therapy with tranquilizers and their drug correction].
    Ben'kovich BI
    Sov Med; 1983; (7):86-9. PubMed ID: 6623185
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.